Ogorek Anthony Joseph’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.93M | Sell |
9,711
-2,373
| -20% | -$2.41M | 2.45% | 13 |
|
|
2025
Q4 | $13M | Sell |
12,084
-371
| -3% | -$355K | 3.57% | 10 |
|
|
2025
Q3 | $9.5M | Buy |
12,455
+1,109
| +10% | +$825K | 2.72% | 14 |
|
|
2025
Q2 | $8.85M | Buy |
11,346
+2
| +0% | +$1.55K | 2.73% | 14 |
|
|
2025
Q1 | $9.37M | Buy |
11,344
+53
| +0.5% | +$44.1K | 3.08% | 10 |
|
|
2024
Q4 | $8.72M | Buy |
11,291
+127
| +1% | +$105K | 2.77% | 10 |
|
|
2024
Q3 | $9.89M | Buy |
11,164
+18
| +0.2% | +$16.2K | 3.39% | 9 |
|
|
2024
Q2 | $10.1M | Sell |
11,146
-24
| -0.2% | -$19.2K | 3.51% | 9 |
|
|
2024
Q1 | $8.69M | Sell |
11,170
-127
| -1% | -$90.4K | 3.02% | 9 |
|
|
2023
Q4 | $6.58M | Sell |
11,297
-25
| -0.2% | -$14.6K | 2.39% | 12 |
|
|
2023
Q3 | $6.08M | Sell |
11,322
-80
| -0.7% | -$41.2K | 2.4% | 15 |
|
|
2023
Q2 | $5.35M | Buy |
11,402
+160
| +1% | +$67.1K | 2.05% | 15 |
|
|
2023
Q1 | $3.86M | Buy |
11,242
+249
| +2% | +$84K | 1.58% | 19 |
|
|
2022
Q4 | $4.02M | Sell |
10,993
-72
| -0.7% | -$25.5K | 1.75% | 16 |
|
|
2022
Q3 | $3.58M | Buy |
11,065
+58
| +0.5% | +$18.4K | 1.7% | 15 |
|
|
2022
Q2 | $3.57M | Buy |
11,007
+250
| +2% | +$75K | 1.64% | 14 |
|
|
2022
Q1 | $3.08M | Buy |
10,757
+3,258
| +43% | +$838K | 1.26% | 20 |
|
|
2021
Q4 | $2.07M | Buy |
7,499
+7,349
| +4,899% | +$1.86M | 0.88% | 22 |
|
|
2021
Q3 | $34K | Hold |
150
| – | – | 0.02% | 92 |
|
|
2021
Q2 | $34K | Hold |
150
| – | – | 0.02% | 90 |
|
|
2021
Q1 | $28K | Hold |
150
| – | – | 0.01% | 92 |
|
|
2020
Q4 | $25K | Hold |
150
| – | – | 0.01% | 83 |
|
|
2020
Q3 | $22K | Buy |
+150
| New | +$23.2K | 0.01% | 75 |
|
Other funds holding LLY
VCM
VPM
